| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 06/13/2007 | EP1794161A2 Muscarinic receptor antagonists |
| 06/13/2007 | EP1214292B1 Tyrosine derivatives |
| 06/13/2007 | CN1980892A Dpp-IV inhibitors |
| 06/13/2007 | CN1980662A 有丝分裂驱动蛋白抑制剂 Mitotic kinesin inhibitors |
| 06/13/2007 | CN1321115C Piperazine derivatives for use as CCR-3 receptor antagonists in the treatment of asthma |
| 06/13/2007 | CN1321101C New retinoids for the treatment of emphysema |
| 06/12/2007 | US7230132 Aryl N-cyanoguanidines and methods related thereto |
| 06/12/2007 | US7230031 Thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof |
| 06/12/2007 | US7230030 Ether, alcohol, ester, carbamate or carbonate,sulfamate or silanol substituted-3,3-diphenylpropylamine derivatives; prodrugs of antimuscarinic agents with superior pharmacokinetic properties |
| 06/12/2007 | US7230020 For therapy of metabolic disorders, such as diabetes and obesity, cardiovascular disorders, such as hypertension, glaucoma, inflammatory disorders, such as arthritis or asthma, immune disorders, bone disorders, such as osteoporosis, cancer |
| 06/12/2007 | US7230018 Substituted propane-1,3-diamine derivatives and the pharmaceutical use thereof |
| 06/12/2007 | US7229994 Analgesics; anxiolytic agents; gastrointestinal disorders |
| 06/12/2007 | CA2354023C Phenylglycine derivatives |
| 06/07/2007 | WO2007064749A1 Compounds for the treatment of inflammatory disorders and microbial diseases |
| 06/07/2007 | WO2007064732A1 Compounds for the treatment of inflammatory disorders and microbial diseases |
| 06/07/2007 | WO2007063925A1 2-aminobenzamide derivative |
| 06/07/2007 | WO2007063789A1 Novel catechol derivative, pharmaceutical composition containing same, and uses of those |
| 06/07/2007 | WO2007063086A1 Novel nk1 and nk2 antagonists |
| 06/07/2007 | WO2007047431A3 Sulfonyl-substituted aryl compounds as modulators of peroxisome proliferator activated receptors |
| 06/07/2007 | WO2007042422A3 Process for the synthesis of amine ethers |
| 06/07/2007 | US20070129440 Polypharmacophoric agents |
| 06/07/2007 | US20070129366 Methods for the treatment of chronic pain and compositions therefor |
| 06/07/2007 | US20070129354 Biphenyl carboxylic amide p38 kinase inhibitors |
| 06/07/2007 | US20070129349 Alpha, beta -peptide inhibitors; Alzheimer's disease; 2-(4-Chloro-benzenesulfonylamino)-3-phenyl-propionic acid methyl ester |
| 06/07/2007 | US20070129310 Antibacterial agents |
| 06/07/2007 | CA2632922A1 Compounds for the treatment of inflammatory disorders and microbial diseases |
| 06/07/2007 | CA2632921A1 Compounds for the treatment of inflammatory disorders and microbial diseases |
| 06/07/2007 | CA2631693A1 Novel nk1 and nk2 antagonists |
| 06/07/2007 | CA2629964A1 2-aminobenzamide derivative |
| 06/06/2007 | EP1792624A1 Modified amino acids and compositions comprising them for delivering active agents |
| 06/06/2007 | EP1791809A1 Substituted aniline derivatives |
| 06/06/2007 | CN1976911A Arylphenylamino-, arylphenylamide-, and arylphenylether-sulfide derivatives |
| 06/06/2007 | CN1976902A N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators |
| 06/06/2007 | CN1976895A Use of alkyloxyalcanic acid amides, in particular in the form of aromatic substances and a novel alkyloxyalcanic acid amide |
| 06/06/2007 | CN1976710A Compounds and compositions as cathepsin S inhibitors |
| 06/06/2007 | CN1976586A Piperazin derivatives and their use in controlling pests |
| 06/06/2007 | CN1974596A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
| 06/06/2007 | CN1319958C Phenyl-piperazine derivatives as serotonin reuptake inhibitors |
| 06/06/2007 | CN1319952C Method for preparing oxazolidone amine |
| 06/05/2007 | US7227022 Use of 2-amino-thiazoline derivatives as inhibitors of inducible no-synthase |
| 06/05/2007 | US7226950 Sodium channel modulators |
| 06/05/2007 | US7226925 Compounds, their use and preparation |
| 06/05/2007 | US7226578 Metal complexes that contain perfluoroalkyl, process for their production and their use in NMR diagnosis |
| 05/31/2007 | US20070123707 Nitrogen-containing monodentate phosphines and their use in catalysis |
| 05/31/2007 | US20070123706 Method for producing 3-amidinophenylalanine derivatives |
| 05/31/2007 | US20070123564 Method for preparing phenyl acetic acid derivatives |
| 05/31/2007 | US20070123509 Carboxamide derivatives |
| 05/31/2007 | US20070123493 Benzamide derivative |
| 05/31/2007 | CA2629935A1 (r)-arylalkylamino derivatives and pharmaceutical compositions containing them |
| 05/30/2007 | EP1177168B1 Caspase inhibitors and the use thereof |
| 05/30/2007 | EP0914605B1 Molecular model for vla-4 inhibitors |
| 05/30/2007 | CN1972920A Arylalkyl-piperazine derivatives for the treatment of conditions ameliorated by monoamine reuptake including vasomotor symptoms |
| 05/30/2007 | CN1972909A Thio-substituted arylmethanesulfinyl derivatives |
| 05/30/2007 | CN1970549A Chiral benzhydryl piperazine derivatives and its preparation method |
| 05/30/2007 | CN1318408C Azo hetercyle beta-elemene derivative and its preparation method and uses |
| 05/30/2007 | CN1318407C Intermediate compound used in synthesizing azo hetercyle beta-elemene derivative and its preparation method |
| 05/30/2007 | CN1318405C Azo heterocycle beta-elemene piperazine alkyl derivative and its preparation and uses |
| 05/29/2007 | USRE39667 3,3-Diphenylpropylamines, their use and preparation |
| 05/29/2007 | US7223879 Reactibng transition metal with boron compound and sulfonate compound |
| 05/29/2007 | US7223796 Acyl-4-carboxyphenylurea derivatives, processes for preparing them and their use |
| 05/29/2007 | US7223765 3-[4-(3,4-Dichlorophenyl)piperazin-1-yl]-1-(2,3-dihydro-1H-indol-1-yl)propan-1-one or salts for example; psychological disorders such as schizophrenia, generalised anxiety disorder, panic disorder, and obsessive compulsive disorder; high affinity for dopamine D4 receptors |
| 05/29/2007 | US7223763 Substituted sulfonamides and ureas useful for inhibiting kinase activity |
| 05/24/2007 | WO2007057681A1 Process for the preparation of delmopinol and derivatives thereof |
| 05/24/2007 | WO2007057403A1 Method for producing ionic liquids |
| 05/24/2007 | WO2007057128A1 Novel dual peptidase inhibitors as prodrugs for the therapy of inflammatory and other disorders |
| 05/24/2007 | WO2007040650A3 Apoptosis promoters |
| 05/24/2007 | WO2006021655A8 Oxopiperidine derivatives, preparation and therapeutic use thereof |
| 05/24/2007 | US20070117799 Oxabispidine compounds useful in the treatment of cardiac arrhythmias |
| 05/24/2007 | US20070117761 Novel ligand activators of the RAR receptors and pharmaceutical/cosmetic applications thereof |
| 05/24/2007 | CA2628921A1 Process for the preparation of delmopinol and derivatives thereof |
| 05/24/2007 | CA2628145A1 Novel dual-use peptidase inhibitors as prodrugs for a therapy of inflammatory and other disorders |
| 05/23/2007 | EP1787987A1 Substituted fullerenes and their use as antioxidants |
| 05/23/2007 | EP1786768A1 Arylsulphonylstilbene derivatives for treatment of insomnia and related conditions |
| 05/23/2007 | EP1786279A1 Method for determining the level of histamine in halieutic products |
| 05/23/2007 | EP1562923B1 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders |
| 05/23/2007 | EP1363885B1 Substituted propane-1,3-diamine derivatives and the pharmaceutical use thereof |
| 05/23/2007 | EP1254895B1 Nitrogenous cyclic compounds and pharmaceutical compositions containing the same |
| 05/23/2007 | CN1968921A Glucagon receptor antagonists, preparation and therapeutic uses |
| 05/23/2007 | CN1968920A Tricyclic aromatic and bis-phenyl sulfinyl derivatives |
| 05/22/2007 | US7220884 Hydroaminomethylation of olefins |
| 05/22/2007 | US7220880 For therapy of diabetes mellitus, cardiovascular disease, obesity, Syndrome X and gastrointestinal disease, such as, inflammatory bowel disease |
| 05/22/2007 | US7220876 Arylcycloalkyl derivatives having branched side chains, processes for their preparation and their use as pharmaceuticals |
| 05/22/2007 | US7220783 Para-terphenyl compounds |
| 05/22/2007 | US7220781 Meta-benzamidine derivatives as serine protease inhibitors |
| 05/22/2007 | US7220752 Liver selective glucocorticoid receptor antagonists; lowering blood glucose levels; 3,5-dibromo-4-(5-isopropyl-2-(3-methylbenzoyl)-4-(3-methyl-3-b utenyloxy)phenoxy)-phenylacetic acid for example |
| 05/22/2007 | US7220749 Nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 05/22/2007 | CA2276694C New fatty acid derivatives |
| 05/22/2007 | CA2266050C Piperazine derivatives |
| 05/22/2007 | CA2157146C Heterocyclyl-benzoylguanidines |
| 05/18/2007 | WO2007056469A2 Certain chemical entities, compositions, and methods |
| 05/18/2007 | WO2007054257A2 Indene derivatives, their preparation and use as medicaments |
| 05/18/2007 | WO2007029036A3 Amino acid derivatives as histone deacetylase (hdac) inhibitors |
| 05/18/2007 | WO2007025696A3 Process for making substituted piperazinyl compounds |
| 05/18/2007 | WO2007006387A3 Onium-alkylsulfonate production method |
| 05/18/2007 | CA2628856A1 Indene derivatives, their preparation and use as medicaments |
| 05/17/2007 | US20070112007 Cyclohexyl-1, 4-diamine compounds |
| 05/17/2007 | US20070112002 1-[2-(4,4-dimethylcyclohexyl)-5-methoxyphenyl]-4-pentylpiperazine; excellent cell adhesion inhibitory action or cell infiltration inhibitory action; inflammatory diseases and autoimmune diseases such as ulcerative colitis, Crohn's disease, irritable bowel syndrome, rheumatoid arthritis, psoriasis, asthma |
| 05/17/2007 | US20070111988 Selective estrogen receptor modulators |
| 05/17/2007 | US20070111987 cyclization using phosphorus oxychloride; antipsychotic or neuroleptic agent for psychological disorders |
| 05/17/2007 | US20070111986 comprises the ring closure and deprotection of an intermediate; 11-(4-[2-(2-hydroxyethoxy)ethyl]-1-piperazinyl]dibenzo[b,f]-1,4-thiazepine; used as an antipsychotic or neuroleptic |